Toronto Dominion Bank
HZNP

Toronto Dominion Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Toronto Dominion Bank’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-360,236
Closed -$41.7M – 1906
2023
Q3 		$41.7M Sell
360,236
-347,520
-49% -$37.3M 0.07% 220
2023
Q2 		$72.7M Buy
707,756
+522,420
+282% +$55.1M 0.11% 154
2023
Q1 		$20.2M Buy
185,336
+185,145
+96,935% +$20.5M 0.03% 327
2022
Q4 		$22K Sell
191
-62
-25% -$5.15K ﹤0.01% 1358
2022
Q3 		$16K Buy
+253
New +$17.7K ﹤0.01% 1430

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Toronto Dominion Bank's HZNP Position: Q4 2023 in Review

Toronto Dominion Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 360,236 shares — an estimated $41.7M sold.

Toronto Dominion Bank first reported a position in HZNP in Q3 2022 and held it in 5 quarters. The position peaked at $72.7M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Toronto Dominion Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 360,236 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $41.7M.
  • Toronto Dominion Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022 and held it in 5 quarters.
  • Toronto Dominion Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $72.7M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.